Tumor-rejection antigens recognized by T lymphocytes.
Generations of immunologists have been searching for evidence to confirm the tantalizing notion that tumor-rejection antigens exist. If found, the ultimate reward was the possibility that these molecules might be used to induce tumor-specific immunity and effect tumor rejection. Until recently rewards have been few and far between. That is changing. The immediate rewards have become more satisfying and the ultimate reward almost palpable.